经印尼卫生部批准，适用于Covid-19的快速抗体测试价格限制已应用。7月6日发布的官方文件已要求，为规范个人需要，例如出差等要求进行个人测试无Covid-19感染等，避免测试价格差异。
COVID-19快速抗体测试价格规定在IDR 150,000 (约为USD 10-11)，适用于所有提供独立快速抗体测试的卫生服务机构。
随着价格限制的实施，公众在使用快速抗体测试将更加透明简便。特别对来往雅加达的商旅人士，因为他们必须提供进出许可信Exit and Entry Permit Letter (SIKM)以及无Covid-19感染证明。该证明可由一些卫生服务机构出具，例如承担Covid-19测试的私人医院、诊所或实验室。
由于需要出具无Covid-19感染证明的要求，许多人已经在私人卫生机构要求进行独立的快速抗体检验，但价格千差万别。在测试终端进行限价被认为是对公众和快速抗体检测机构双方必要的澄清和确认。
政府卫生机构仍为感染者或疑似感染者密切接触的人员提供Covid-19测试，政府卫生机构不能为出差目的而获得无Covid-19感染证明的人士提供测试。
关于制裁处罚，卫生部还未为违反价格限定制定具体的制裁处罚措施。卫生部进一步考察与价格相关的各方面因素，在社区、健康设施、医疗人员、经销商和快速测试设备提供者。
A COVID-19 test price limit has been introduced in Indonesia for Rapid Antibody Test Kits by the Director General of Health Services of the Ministry of Health (MOH). The official circular issued on 6th July 2020 has been primarily introduced to avoid price variations in test kits for the public who personally request an independent test in order to obtain a COVID-19 free certificate for travel purposes.
The COVID-19 test price limit for rapid antibody tests has been set at IDR 150,000 (roughly equivalent to USD 10-11) and applies to all health services which provide rapid antibody tests independently.
With a clear price limit in place, the public is guaranteed more transparency and easier access to Rapid Antibody Test examination services. This is of particular importance for people who travel to and from Jakarta city as they must provide an Exit and Entry Permit Letter (SIKM) together with a COVID-19 free certificate. This certificate can be issued by health services such as private hospitals, clinics or laboratories that have carried out a COVID-19 test on the person concerned.
Due to the requirement for a COVID-19 free certificate, many people have requested independent rapid antibody examinations at private health facilities at widely varying prices. The introduction of a maximum retail price was deemed necessary to provide clarity and certainty for both the public as well as providers of Rapid Antibody Test examination services.
COVID-19 testing remains available at Government health facilities for those people who have been in close contact with a positive case or the person themself is a suspect case, i.e. Government health facilities cannot be used for testing simply to obtain a certificate for travel purposes.
Regarding sanctions, the Ministry of Health has not yet established concrete sanctions related to violations of the rapid test retail price limit. The Ministry of Health will look further into various aspects related to pricing, both in terms of the community, health care facilities, medical personnel, distributors, and providers of rapid test equipment.
日本PMDA注册：
美国FDA注册：
印尼医械注册：
欧盟CE：
俄罗斯RZN注册：
澳大利亚TGA注册：
中国香港医械注册：
菲律宾FDA注册：
联系客服
